The Patent Finder

Rexahn Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Rexahn Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Rexahn Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,150,520Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-CYCLOPENT-2-ENYL)-1H-PYRIMIDIN-2-ONE
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,533,958Process or the preparation of 4-amino 1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-Enyl)-1H-pyrimidin-2-one
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,920,016Process for the Preparation of 4-Amino-1-((1S,4R,5S)-2-Fluoro-4,5-Dihydroxy-3-Hydroxymethyl-Cyclopent-2-Enyl)-1H-Pyrimidin-2-One
Formerly held
In force
 · Low confidence
In forceLow confidence
US 9,782,410Fluorocyclopentenylcytosine methods of use
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,278,971Fluorocyclopentenylcytosine methods of use
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,405,214Nucleoside derivatives and therapeutic use thereof
Formerly held
Term ended
Term ended Aug 24, 2025 · From the USPTO record
Term endedTerm ended Aug 24, 2025From the USPTO record
US 7,205,283Antisense oligonucleotides that inhibit expression of HIF-1
Formerly held
Term ended
Term ended Jun 16, 2025 · From the USPTO record
Term endedTerm ended Jun 16, 2025From the USPTO record
US 7,388,014Quinazoline derivatives and therapeutic use thereof
Formerly held
Term ended
Term ended Feb 17, 2025 · From the USPTO record
Term endedTerm ended Feb 17, 2025From the USPTO record
US 7,122,527Use of antisense oligonucleotides to inhibit the expression of human Akt-1
Formerly held
Term ended
Term ended Feb 10, 2025 · From the USPTO record
Term endedTerm ended Feb 10, 2025From the USPTO record
US 8,314,1001-[6,7-Substituted Alkoxyquinoxalinyl) AMINOCARBONYL]-4-(HETERO) Arylpiperazine Derivatives
Formerly held
Lapsed on the fee record
Ended Nov 20, 2024 · High confidence
Lapsed on the fee recordEnded Nov 20, 2024High confidence
10 of 22 patents shown.
Pro members see all 22.
Pro members: see all 22 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited